UPDATE: Credit Suisse Downgrades Cubist Pharmaceuticals On Execution Risk To Global Expansion Of Hospital Franchise

By: via Benzinga
In a report published Thursday, Credit Suisse analyst Jason Kantor downgraded the rating on Cubist Pharmaceuticals Inc (NASDAQ: CBST) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.